Evidence map›Paper›PMID 27271689›Full record

ArticleInflammopharmacology2016

Poly-ADP-ribose polymerase inhibition provides protection against lung injury in a rat paraquat toxicity model.

Salim Kemal Tuncer, Seher Altinel, Mehmet Toygar, Hakan Istanbulluoglu, Kahraman Ates, Recai Ogur, Ozcan Altinel, Yildirim Karslioglu, Turgut Topal, Ahmet Korkmaz and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept.American journal of respiratory cell and molecular biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Salim Kemal TuncerDepartment of Emergency Medicine, Gulhane Military Medical Academy, Ankara, Turkey.
Seher AltinelDepartment of Anesthesia and Reanimation, Dr. Abdurrahman Yurtaslan, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
Mehmet ToygarDepartment of Forensic Medicine, Gulhane Military Medical Academy, Ankara, Turkey.
Hakan IstanbulluogluDepartment of Public Health, Gulhane Military Medical Academy, Ankara, Turkey.
Kahraman AtesDepartment of Biophysics, Gulhane Military Medical Academy, Ankara, Turkey.
Recai OgurDepartment of Public Health, Gulhane Military Medical Academy, Ankara, Turkey.
Ozcan AltinelDepartment of Noncommissioned Officer Health College, Gulhane Military Medical Academy, Ankara, Turkey.
Yildirim KarsliogluDepartment of Pathology, Gulhane Military Medical Academy, Ankara, Turkey.
Turgut TopalDepartment of Physiology, Gulhane Military Medical Academy, Ankara, 06010, Turkey.
Ahmet KorkmazDepartment of Physiology, Gulhane Military Medical Academy, Ankara, 06010, Turkey.
Bulent UysalDepartment of Physiology, Gulhane Military Medical Academy, Ankara, 06010, Turkey. buysal@gata.edu.tr.
Turkish Armed Forces · TRAnkara Onkoloji Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesParaquat (PQ) is a widely used herbicide. Exposure to PQ at toxic doses can result in fatal acute lung injury. Inhibition of the poly-(ADP-ribose) polymerase (PARP) enzyme alleviates inflammation and necrosis in various pathologies. Here we aimed to evaluate the effects of PARP inhibition on PQ-induced lung damage in a rat experimental model.

methodsFemale Sprague-Dawley rats (n = 24) were allocated into three groups: sham, PQ and PQ + 3-aminobenzamide (3-AB) that is a PARP inhibitor, groups. Experimental lung injury was induced by administration of 15 mg/kg PQ intraperitoneally in PQ and PQ + 3-AB groups. 3-AB (10 mg/kg twice per day) was administered to the PQ + 3-AB group for four consecutive days. The animals were killed on the fifth day following PQ administration. Lung tissue and blood samples were collected and stored until analysis.

resultsSerum lactate dehydrogenase (LDH) and neopterin levels, tissue oxidative stress parameters, transforming growth factor-beta1 (TGF-β) levels and histological injury scores in the PQ + 3-AB group were significantly lower than in the PQ group (P < 0.05, PQ vs. PQ + 3-AB). Total antioxidant capacity in the PQ + 3-AB group was significantly higher than in the PQ group (P < 0.05, PQ + 3-AB vs. PQ).

conclusionOur results suggested that the use of PARP inhibitors following PQ toxicity might be useful for minimizing lung injury due to paraquat toxicity.

Indexed as

AnimalsAntioxidantsBenzamidesBiomarkersDisease Models, AnimalFemaleInjections, IntraperitonealLipid PeroxidationLung InjuryNeopterinParaquatPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesRats, Sprague-Dawley3-aminobenzamideAntioxidantsBenzamidesBiomarkersNeopterinParaquatPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesLung injuryNeopterinParaquat toxicityPARP inhibitionTGF-β1

Identifiers

PMID27271689
OpenAlexW2418754718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.